Prevalencia y factores de riesgo asociados a la dislipidemia en pacientes diabéticos tipo 2 de la Comunidad de Cantabria

Vera, Alcibíades Segundo Díaz; Alemán, José Abellán; Fragoso, António; Esteban, Juan Pablo Martínez de; Couso, Francisco Javier Lameiro; Rabanal, Miladi del Socorro Golac; Vera, Luis; Matta-Solís, Hernán

doi:10.1016/j.endinu.2019.04.010

Cited by 4 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The frequency of dyslipidemia and hypertension was lower than that observed in two recent studies conducted in Catalonia and Cantabria health areas in Spain [20,21]. While the frequency of obesity and smoking habit was higher [11,20,21].…”

Section: Discussioncontrasting

confidence: 64%

Evaluation of the Fulfilment of the Therapeutic Objectives in Type 2 Diabetes People Attended in Primary Care Centres in Northwest Spain

2023

Endocrinol Diabetes Metab J

View full text Add to dashboard Cite

Objective: To know the degree of fulfilment of the treatment goals for DM2 patients.Methods: Adult DM2 patients. Descriptive, observational and transversal design. Study variables: Process: % of patients with determination of BMI, abdominal perimeter, foot exploration, arterial pressure, EKG, ophthalmoscopy and HbA1c, lipid profile, microalbuminuria, glomerular filtration rate. Intermediate results: % of patients with overweight/obesity, active smokers, HbA1c value <7%, blood pressure <140/90, normal lipid profile, negative microalbuminuria. Final results: % of patients with foot ulcers, amputation, diabetic retinopathy, renal failure, coronary disease, cerebrovascular disease, peripheral arteriopathy and acute complications. Results:The study include 1,029 DM patients 55% male, mean age 67 ± 0.8 years old. The % of patients with overweight, obesity, hypertension, dyslipemia, were 32.5%, 59.4%, 63.8%, and 64% respectively. The 94% have HbA1c determination, 47% ophthalmoscopy, while only 2,2 foot examination. The percent of patients with

show abstract

Section: Discussioncontrasting

confidence: 64%

Evaluation of the Fulfilment of the Therapeutic Objectives in Type 2 Diabetes People Attended in Primary Care Centres in Northwest Spain

2023

Endocrinol Diabetes Metab J

View full text Add to dashboard Cite

show abstract

A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents

et al. 2021

View full text Add to dashboard Cite

Introduction: This study aimed to investigate the relationships between timing of the first physician visit after detection of an abnormal glycated hemoglobin (HbA1c) value at routine annual check and the time to antidiabetic treatment prescription; and understand treatment patterns in patients newly diagnosed with type 2 diabetes mellitus (T2DM). Methods: This retrospective, longitudinal, observational cohort study examined data from JMDC Inc., an administrative claims database. Patients with HbA1c value of at least 6.5% at routine annual check, aged 20 years or older, and prescribed at least one antidiabetic drug were included. This cohort was classified into early physician visit and delayed physician visit groups based on the timing of the first physician visit relative to the median. Patients were monitored from the date of first HbA1c checkup of at least 6.5% to the date of first physician visit with an HbA1c test, and from the date of the first physician visit to the date of prescription of first-line and second-line T2DM treatments. The time to first prescription of antidiabetic treatment for the two groups was then compared. Results: Of 4798 eligible patients, 54.8% were prescribed first-line T2DM therapy less than 2 months from the first physician visit for T2DM diagnosis. A lower percentage of the early group compared with the delayed group required T2DM pharmacological therapy in less than 2 months (46.1% vs. 63.4%). The early group had a longer median time to prescription of first-line therapy [92 days vs. 15 days, p \ 0.0001; hazard ratio (HR) 1.31, 95% confidence interval (CI) 1.24, 1.39] and second-line therapy (1599 days vs. 1315 days, p \ 0.0001; HR 1.22, 95% CI 1.11, 1.34) compared with the delayed group. Conclusion:In Japanese patients with T2DM, early physician visit after abnormal HbA1c detection at routine annual check is associated with a longer period before T2DM medication requirement, and may improve disease course.

show abstract

Clinical relevance of midkine as a biomarker predicting atherosclerotic risk factors in individuals with type-2 diabetes mellitus: a cross-sectional study

Salman,

Mohammed,

Shaban

et al. 2024

J Diabetes Metab Disord

View full text Add to dashboard Cite

Prevalencia y factores de riesgo asociados a la dislipidemia en pacientes diabéticos tipo 2 de la Comunidad de Cantabria

Cited by 4 publications

References 27 publications

Evaluation of the Fulfilment of the Therapeutic Objectives in Type 2 Diabetes People Attended in Primary Care Centres in Northwest Spain

Evaluation of the Fulfilment of the Therapeutic Objectives in Type 2 Diabetes People Attended in Primary Care Centres in Northwest Spain

A Claims-Based Cohort Study on the Treatment Patterns of Japanese Patients with Type 2 Diabetes Mellitus and the Association of Early First Physician Visit with Time to Prescription of Oral Hypoglycemic Agents

Clinical relevance of midkine as a biomarker predicting atherosclerotic risk factors in individuals with type-2 diabetes mellitus: a cross-sectional study

Contact Info

Product

Resources

About